Indivior Pharmaceuticals Inc Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 317.0M | 358.0M | 314.0M | 302.0M | 266.0M | 299.0M | 307.0M | 299.0M |
| Cost of Goods Sold | 40.0M | 64.0M | 62.0M | 52.0M | 44.0M | 23.0M | 69.0M | 79.0M |
| Gross Profit | 277.0M | 294.0M | 252.0M | 250.0M | 222.0M | 276.0M | 238.0M | 220.0M |
| R&D Expenses | 16.0M | 17.0M | 20.0M | 21.0M | 22.0M | 31.0M | 22.0M | 26.0M |
| Operating Expenses | 140.0M | 172.0M | 153.0M | 178.0M | 156.0M | 180.0M | 234.0M | 338.0M |
| Operating Income | 137.0M | 122.0M | 99.0M | 72.0M | 66.0M | 96.0M | 4.0M | -118.0M |
| Other Income / Gains | -22.0M | -41.0M | -62.0M | -10.0M | -7.0M | -8.0M | -5.0M | -3.0M |
| Net Income | 89.0M | 102.0M | 42.0M | 18.0M | 47.0M | 59.0M | 4.0M | -97.0M |
| EPS (Diluted) | 0.71 | 0.82 | 0.34 | 0.14 | 0.38 | 0.45 | 0.03 | -0.72 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0.874 | 0.821 | 0.803 | 0.828 | 0.835 | 0.923 | 0.775 | 0.736 |
| General And Administrative Expenses | 0 | 0 | 0 | 158.0M | 65.0M | -302.0M | 208.0M | 152.0M |
| Selling And Marketing Expenses | 0 | 0 | 0 | 0 | 67.0M | 255.0M | 0 | 0 |
| Selling General And Administrative Expenses | 124.0M | 155.0M | 133.0M | 158.0M | 132.0M | -47.0M | 208.0M | 152.0M |
| Other Expenses | 0 | 0 | 0 | -1.0M | 2.0M | 196.0M | 4.0M | 160.0M |
| Cost And Expenses | 180.0M | 236.0M | 215.0M | 230.0M | 200.0M | 203.0M | 303.0M | 417.0M |
| Interest Income | 3.0M | 6.0M | 6.0M | 6.0M | 4.0M | 5.0M | 5.0M | 6.0M |
| Interest Expense | 7.0M | 6.0M | 12.0M | 15.0M | 12.0M | 13.0M | 10.0M | 9.0M |
| Depreciation And Amortization | 2.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 13.0M | 6.0M |
| Ebitda | 139.0M | 127.0M | 104.0M | 82.0M | 76.0M | 106.0M | 22.0M | -106.0M |
| Ebitdaratio | 0.438 | 0.355 | 0.331 | 0.272 | 0.286 | 0.355 | 0.072 | -0.355 |
| Operating Income Ratio | 0.432 | 0.341 | 0.315 | 0.238 | 0.248 | 0.321 | 0.013 | -0.395 |
| Income Before Tax | 115.0M | 81.0M | 37.0M | 62.0M | 59.0M | 88.0M | -1.0M | -121.0M |
| Income Before Tax Ratio | 0.363 | 0.226 | 0.118 | 0.205 | 0.222 | 0.294 | -0.003 | -0.405 |
| Income Tax Expense | 26.0M | -21.0M | -5.0M | 44.0M | 11.0M | 28.0M | -5.0M | -23.0M |
| Net Income Ratio | 0.281 | 0.285 | 0.134 | 0.06 | 0.177 | 0.197 | 0.013 | -0.324 |
| Epsdiluted | 0.69 | 0.82 | 0.33 | 0.14 | 0.38 | 0.45 | 0.03 | -0.72 |
| Weighted Average Shs Out | 125.4M | 125.0M | 125.0M | 123.7M | 123.7M | 126.6M | 132.1M | 134.8M |
| Weighted Average Shs Out Dil | 129.0M | 125.0M | 129.0M | 123.7M | 123.7M | 128.1M | 133.6M | 134.8M |